LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Agency warns the public to be on the lookout as counterfeit at-home OTC COVID-19 diagnostic tests appear on the US market.
New report shows a fair portion of prior authorization and physician reimbursement request denials actually met Medicare coverage rules.
In last week’s announced enforcement actions involving the healthcare industry, two defendants were sentenced, one was convicted, and two others were charged in various fraud-related schemes.
Case is part of a larger coordinated enforcement action targeting COVID-19-related fraud spanning seven judicial districts.
A research team has developed a new, simpler microfluidic chip that could make at-home diagnosis of diseases faster and more affordable
For the third straight year since the PAMA pricing system has been in place, overall year-over-year spending on lab tests increased in FY 2020.
The agency recently issued draft guidance to medical device manufacturers to help protect their products from cyberattacks.
April 27 webinar featuring an update on the brand and talk on recent lab industry developments sees strong engagement.
Recent case highlights importance of having an actual written analysis in your records justifying use of a certain code.
The Biden administration released another statement on Wednesday reminding lawmakers of the consequences of not resolving the issue quickly.